New gel delivery system overcomes challenges of intratumoral cancer immunotherapy

Intratumoral therapy – in which cancer drugs are injected directly into tumors – is a promising treatment option for solid cancers but has shown limited success in clinical trials due to an inability to precisely deliver the drug and because most immunotherapies quickly dissipate from the site of injection.

Related Keywords

Massachusetts ,United States ,Eric Wehrenberg Klee ,Giovanni Traverso ,Department Of Medicine At Brigham ,Department Of Radiology At Massachusetts ,Department Of Mechanical Engineering ,Koch Institute For Integrative Cancer Research ,Mass General Brigham ,Koch Institute ,Integrative Cancer Research ,Advanced Healthcare Materials ,Massachusetts General Hospital ,Mechanical Engineering ,Cancer ,Drugs ,Breast Cancer ,Ancer Immunotherapy ,Colon ,It ,Healthcare ,Hospital ,Maging ,Immune System ,Immunotherapy ,Medicine ,Radiology ,Research ,Technology ,Humor ,